Therefore, the overexpression of MAP17 increases the cancer stem cell-like pool of tumor cells, independently of the tumor origin of the cells, while the downregulation of the protein in cells that endogenously expresses it, triggers the reduction of this cancer stem cell pool [51]. Here, PDZK1IP1 is linked to neoplasm.